Cargando…
CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
OBJECTIVE: CD133 has recently been reported as a marker of cancer stem-like cells in colorectal cancer (CRC). However, its predictive value in CRC still remains controversial. In this study, we aimed to evaluate the association between the expression of CD133 and clinicopathological features and the...
Autores principales: | Chen, Shicai, Song, Xinming, Chen, Zhihui, Li, Xinxin, Li, Mingzhe, Liu, Haiying, Li, Jianchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569427/ https://www.ncbi.nlm.nih.gov/pubmed/23409180 http://dx.doi.org/10.1371/journal.pone.0056380 |
Ejemplares similares
-
Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma
por: Park, Youn Young, et al.
Publicado: (2019) -
Augmented CD133 expression in distal margin correlates with poor prognosis in colorectal cancer
por: Pradhan, Tapas, et al.
Publicado: (2019) -
Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
por: Wang, Ke, et al.
Publicado: (2012) -
Elevated expression of CXCL16 correlates with poor prognosis in patients with colorectal cancer
por: Chen, Zhihui, et al.
Publicado: (2019) -
CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies
por: Huang, Rongyong, et al.
Publicado: (2018)